Board of Education of Joliet Township High School, District 204 v. Publicis Health, LLC

CourtDistrict Court, N.D. Illinois
DecidedSeptember 8, 2025
Docket1:24-cv-11435
StatusUnknown

This text of Board of Education of Joliet Township High School, District 204 v. Publicis Health, LLC (Board of Education of Joliet Township High School, District 204 v. Publicis Health, LLC) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Board of Education of Joliet Township High School, District 204 v. Publicis Health, LLC, (N.D. Ill. 2025).

Opinion

UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

BOARD OF EDUCATION OF JOLIET TOWNSHIP HIGH SCHOOL, DISTRICT 204, et. al.,

Plaintiffs, No. 24 CV 11435 V. Judge Manish S. Shah PUBLICIS HEALTH, LLC, PRACTICE FUSION, INC., VERADIGM, INC., and ZS ASSOCIATES,

Defendants.

MEMORANDUM OPINION AND ORDER

Some school districts incurred the costs of educating children born with disabilities resulting from maternal opioid use. They accuse defendants, marketing and consulting companies who assisted drug manufacturers in increasing opioid sales, of racketeering. Defendants move to dismiss for lack of subject-matter jurisdiction and failure to state a claim. Profiting from the opioid epidemic warrants, in appropriate cases, accountability. But the connection between the school districts and these defendants is too attenuated for a racketeering claim. Without a federal claim to ground this court’s jurisdiction, or compelling reasons to retain supplemental jurisdiction, the companion state-law claims are also dismissed. I. Legal Standards To survive a motion to dismiss, a complaint must contain “a short and plain statement of the claim showing that the pleader is entitled to relief.” Fed. R. Civ. P. 8(a). When analyzing the sufficiency of a complaint, I construe it in the light most favorable to the plaintiffs, accepting all well-pleaded facts as true and drawing all inferences in their favor. Ratfield v. U.S. Drug Testing Lab’y, Inc., 140 F.4th 849, 852 (7th Cir. 2025).

Rule 8(a) “does not demand detailed factual allegations, but it does require more than mere ‘labels and conclusions,’ or a ‘formulaic recitation of the elements of a cause of action.’” Wertymer v. Walmart, Inc., 142 F.4th 491, 494–95 (7th Cir. 2025) (citing Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 555 (2007)). “The complaint must contain sufficient factual matter, accepted as true, to state a claim for relief that is plausible on its face.” Id. (citing Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009)).

Beyond the requirements of 8(a), because the school districts ground their racketeering claim in allegations of mail and wire fraud, they “must state with particularity the circumstances constituting fraud or mistake.” Fed. R. Civ. P. 9(b); Ratfield, 140 F.4th at 852 (“Moreover, because Plaintiffs’ civil RICO claims sound in fraud, the circumstances must be described ‘with particularity’ to satisfy Rule 9(b)’s heightened pleading requirement.”). II. Background

Because plaintiff school districts allege that the defendants here conspired with McKinsey & Co. to enlarge the opioid market, many of the allegations in this complaint mirror or resemble those made by the school districts in the McKinsey opiate litigation. Compare Master Complaint (School Districts), In re: McKinsey & Co., Inc. National Prescription Opiate Consultant Litigation, 3:21-md-02996-CRB (N.D. Cal. Dec. 6, 2021), Dkt. No. 297 with [8].1 For the purposes of brevity, I incorporate by reference Judge Breyer’s discussion of the opioid epidemic, neonatal abstinence syndrome (also known as neonatal opioid withdrawal syndrome), and the

pharmaceutical-consultant enterprise from In re McKinsey & Co., Inc. Natl. Prescription Opiate Litig., 3:21-md-02996-CRB, 2024 WL 2261926 (N.D. Cal. May 16, 2024). While the complaint contains extensive allegations pertaining to the defendants’ conduct, the relevant facts for the disposition of this case all pertain to the plaintiffs and their theory of harm. Defendants’ marketing practices sought to increase profits from opioids by

changing prescriber habits and public perception regarding the safety and efficacy of opioids. [8] ¶ VIII.52.2 To achieve that goal, defendants targeted different segments of prescribers with marketing strategies focused on increasing dosage instead of discontinuing treatment when the patient became tolerant. [8] ¶¶ VIII.64–VIII.67. The marketing strategy successfully led to more patients and higher dosages. [8] ¶ VIII.68. Higher dosages for longer periods of time led to more cases of addiction.

[8] ¶ VIII.67. More cases of addiction led to more people using opioids during

1 Bracketed numbers refer to entries on the district court docket. Referenced page numbers are taken from the CM/ECF header placed at the top of filings. The facts are taken from the unsealed complaint, [8]. Plaintiffs filed an unredacted version of the complaint under seal, but the redactions are immaterial to resolving this motion, so all citations are to the public filing. 2 The paragraph numbering in the complaint starts over at the beginning of Part VIII, on page 168. To distinguish between the two sets of numbering, the prefix “VIII.” will be appended to paragraph numbers from page 168 onwards. pregnancy. [8] ¶ 27. More opioid use during pregnancy led to more infants born with neonatal opioid withdrawal syndrome. [8] ¶ 27. Children born with neonatal opioid withdrawal syndrome are substantially more likely to be diagnosed with educational

disabilities. [8] ¶ 540. Once those children reach school age, the responsibility of providing federally mandated special education services falls to schools. [8] ¶ 27. As a result, plaintiffs incurred costs for hazardous waste abatement, medical care to students suffering from opioid-related illnesses, first-responder training, opioid overdose treatment medications, mental health services for victims of the opioid epidemic and their families, and care for children whose parents suffer from

opioid-related disability. [8] ¶ VIII.146. To recover for those injuries, plaintiffs now sue defendants Publicis Health, ZS Associates, Practice Fusion, and Veradigm under six causes of action: federal RICO, negligence, gross negligence, public nuisance, civil conspiracy, and civil aiding and abetting. [8] ¶¶ VIII.1–VIII.184; VIII.551–VIII.555. III. Analysis A. Improper Parties Two parts of this case need to be dismissed before reaching the merits of any claim. First, two states have released all claims held by their subdivisions against

Publicis Health. As plaintiffs concede, all claims held by New York subdivisions against entities released in a statewide opioid settlement are barred by New York statute. [49] at 34; N.Y. Mental Hyg. L. § 25.18. Plaintiffs contend that a corresponding Illinois statute does not have the same effect, but their reading is mistaken. See 735 ILCS 5/13-226 (“On and after [July 9, 2021], no unit of local government or school district may file or become a party to opioid litigation against an opioid defendant that is subject to a national multistate opioid settlement unless approved by the Attorney General.”). Publicis Health—but not the other defendants—has agreed to a multistate settlement of its claims, [35-21] (Illinois Final

Judgment and Consent Decree), [35-29] (New York Consent Order and Judgment), so the Illinois and New York subdivisions’ claims against Publicis Health are barred. Second, although plaintiffs name Veradigm as a defendant in this case, they have failed to assert any substantive allegations against it. See [8]. In their consolidated response to defendants’ motions to dismiss, as well as their sur-reply, plaintiffs did not mention Veradigm other than in the case caption. See [49], [53-1].

Plaintiffs have therefore forfeited any arguments against dismissing Veradigm. Firestone Fin. Corp. v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Hawaii v. Standard Oil Co. of Cal.
405 U.S. 251 (Supreme Court, 1972)
Oneida Indian Nation v. County of Oneida
414 U.S. 661 (Supreme Court, 1974)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Dillon v. Combs
895 F.2d 1175 (Seventh Circuit, 1990)
Frederick H. Groce v. Eli Lilly & Company
193 F.3d 496 (Seventh Circuit, 1999)
Canyon County v. Syngenta Seeds, Inc.
519 F.3d 969 (Ninth Circuit, 2008)
Steel Co. v. Citizens for a Better Environment
523 U.S. 83 (Supreme Court, 1998)
El Paso County Texas v. Bank of America Cor
557 F. App'x 383 (Fifth Circuit, 2014)
Sabrina Roppo v. Travelers Commercial Insurance
869 F.3d 568 (Seventh Circuit, 2017)
Fiala v. B & B Enterprises
738 F.3d 847 (Seventh Circuit, 2013)
Firestone Financial Corp. v. Meyer
796 F.3d 822 (Seventh Circuit, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
Board of Education of Joliet Township High School, District 204 v. Publicis Health, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/board-of-education-of-joliet-township-high-school-district-204-v-publicis-ilnd-2025.